Genetic linkage of serum homocysteine in dominican families: The family study of stroke risk and carotid atherosclerosis

Stroke

Volumn 41, Issue 7, 2010, Pages 1356-1362

  Della Morte, David ^a   Beecham, Ashley ^a   Rundek, Tatjana ^a   Slifer, Susan ^a   Boden Albala, Bernadette ^b   McClendon, Mark S ^a   Blanton, Susan H ^a   Sacco, Ralph L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Mailman School of Public Health Columbia University ^*  (United States)

Author keywords

cardiovascular disease; Dominican families; genetic linkage; homocysteine

Indexed keywords

CREATININE; CYANOCOBALAMIN; DNA; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; METHYLMALONIC ACID; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXINE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHROMOSOME 17Q; CHROMOSOME 2; CYANOCOBALAMIN DEFICIENCY; DOMINICAN REPUBLIC; FAMILY STUDY; FEMALE; GENE; GENETIC LINKAGE; GENOTYPE; HERITABILITY; HIGH RISK POPULATION; HUMAN; INTERVIEW; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METTL 2A GENE; MICROSATELLITE MARKER; NUTRITIONAL STATUS; PNMT GENE; PNPO GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE TRAIT LOCUS; QUESTIONNAIRE; STROKE; THUMPD 2 GENE; WAIST CIRCUMFERENCE; BLOOD; CAROTID ARTERY DISEASE; COMPARATIVE STUDY; ETHNOLOGY; GENETICS; MIDDLE AGED; RISK FACTOR; UNITED STATES;

ADULT; CAROTID ARTERY DISEASES; DOMINICAN REPUBLIC; FEMALE; HOMOCYSTEINE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; STROKE;

EID: 77954177581     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.573626     Document Type: Article

References (33)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart Disease and Stroke Statistics\2009 update: a report from the Am Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-e181.
2. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR, Jacobsen DW, Brattstrom L, Wilcken B, Wilcken DE, Blom HJ, Stabler SP, Allen RH, Selhub J, Rosenberg IH. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol. 2000;20:1704-1706.
3. Pinto X, Vilaseca MA, Garcia-Giralt N, Ferrer I, Pala M, Meco JF, Mainou C, Ordovas JM, Grinberg D, Balcells S. Homocysteine and the MTHFR 677C->T allele in premature coronary artery disease. Case control and family studies. Eur J Clin Invest. 2001;31:24-30.
4. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke. 2004;35:2263-2269. (Pubitemid 39311247)
5. Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol. 2008;59:155-167.
6. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
7. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-1577.
8. Spence JD, Bang H, Chambless LE, Stampfer MJ. Vitamin intervention for stroke prevention trial: an efficacy analysis. Stroke. 2005;36: 2404-2409.
9. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578-1588.
10. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
11. Kullo IJ, Ding K, Boerwinkle E, Turner ST, Mosley TH Jr, Kardia SL, de Andrade M. Novel genomic loci influencing plasma homocysteine levels. Stroke. 2006;37:1703-1709.
12. Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordonez-Llanos J, Martin-Campos JM, Lathrop M, Stone W, Blangero J, Fontcuberta J. A genomewide exploration suggests a new candidate gene at Chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT Project. Am J Hum Genet. 2005;76:925-933.
13. Sacco RL, Sabala EA, Rundek T, Juo SH, Huang JS, DiTullio M, Homma S, Almonte K, Lithgow CG, Boden-Albala B. Design of a family study among high-risk Caribbean Hispanics: the Northern Manhattan Family Study. Ethn Dis. 2007;17:351-357.
14. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
15. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453-469.
16. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquan-titative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
17. Huang MH, Schocken M, Block G, Sowers M, Gold E, Sternfeld B, Seeman T, Greendale GA. Variation in nutrient intakes by ethnicity: results from the Study of Women's Health Across the Nation (SWAN). Menopause. 2002;9:309-319. (Pubitemid 36701890)
18. Stabler SP, Marcell PD, Podell ER, Allen RH. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem. 1987;162:185-196.
19. Epstein MP, Duren WL, Boehnke M. Improved inference of relationship for pairs of individuals. Am J Hum Genet. 2000;67:1219-1231.
20. McPeek MS, Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet. 2000;66:1076-1094.
21. O'Connell JR, Weeks DE. Pedcheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998; 63:259-266.
22. Hauser ER, Watanabe RM, Duren WL, Bass MP, Langefeld CD, Boehnke M. Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol. 2004;27:53-63.
23. Ray JG, Harvey DT. Hyperhomocysteinemia as a cause of premature stroke in a young patient. Arch Phys Med Rehabil. 1998;79:343-345.
24. Vermeulen SH, van der Vleuten GM, de Graaf J, Hermus AR, Blom HJ, Stalenhoef AF, den Heijer M. A genome-wide linkage scan for homocysteine levels suggests three regions of interest. J Thromb Haemost. 2006;4:1303-1307.
25. Wilson A, Leclerc D, Saberi F, Campeau E, Hwang HY, Shane B, Phillips JA III, Rosenblatt DS, Gravel RA. Functionally null mutations in patients with the CBLG-variant form of methionine synthase deficiency. Am J Hum Genet. 1998;63:409-414.
26. Lievers KJ, Kluijtmans LA, Blom HJ. Genetics of hyperhomocys-teinaemia in cardiovascular disease. Ann Clin Biochem. 2003;40:46-59.
27. Houston DM, Matuszewska B, Borchardt RT. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 10. Base-and amino acid modified analogues of S-aristeromycinyl-l-homocysteine. J Med Chem. 1985;28:478-482.
28. Ngo EO, LePage GR, Thanassi JW, Meisler N, Nutter LM. Absence of pyridoxine-5'-phosphate oxidase (PNPO) activity in neoplastic cells: isolation, characterization, and expression of PNPO cDNA. Biochemistry. 1998;37:7741-7748.
29. Shatrov VA, Ameyar M, Cai Z, Bettaieb A, Chouaib S. Methyltransferase inhibitor S-adenosyl-l-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathway. Eur Cytokine Netw. 1999;10:247-252.
30. Armengaud J, Urbonavicius J, Fernandez B, Chaussinand G, Bujnicki JM, Grosjean H. N2-methylation of guanosine at position 10 in tRNA is catalyzed by a THUMP domain-containing, S-adenosylmethionine-dependent methyltransferase, conserved in Archaea and Eukaryota. J Biol Chem. 2004;279:37142-37152.
31. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, Fisher KD, Mulinare J, Osterloh JD. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr. 2007;86:718-727.
32. Selhub J, Morris MS, Jacques PF. In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and meth-ylmalonic acid concentrations. Proc Natl Acad Sci USA. 2007;104: 19995-20000.
33. Cai G, Cole SA, Bastarrachea RA, Maccluer JW, Blangero J, Comuzzie AG. Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22. Am J Clin Nutr. 2004;80:1410-1414.